The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckmann, M. P.
Right arrow Articles by Park, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckmann, M. P.
Right arrow Articles by Park, L. S.

The Journal of Immunology, Vol 144, Issue 11 4212-4217, Copyright © 1990 by American Association of Immunologists


ARTICLES

Monoclonal antibodies block murine IL-4 receptor function

MP Beckmann, KA Schooley, B Gallis, T Vanden Bos, D Friend, AR Alpert, R Raunio, KS Prickett, PE Baker and LS Park
Immunex Corporation, Seattle, WA 98101.

IL-4 is a cytokine which can induce B-lymphocyte proliferation, increase cell-surface Ia expression, and induce some activated B cells to differentiate and begin to secrete IgE. IL-4 binds specifically to a cell-surface receptor (IL-4R) on cells from a variety of lineages including T and B cells. In general both primary cells and in vitro cell lines express less than 5000 receptors per cell. Utilizing a subclone of the cytotoxic T cell line CTLL-2 expressing a high level of IL-4R, mAb against the murine IL-4R were prepared. Two mAb have been identified which have different properties. These antibodies, designated M1 and M2, recognize sequences specific to the murine IL-4R. Immunoprecipitation studies with M1 and M2 on CTLL-2 cells have identified the receptor as a Mr = 145,000 cell-surface protein. Similar results have been obtained with the recently isolated full length murine IL-4R cDNA expressed in COS-7 cells. In addition the antibodies are capable of inhibiting IL-4 binding. One antibody, M1, is also a potent inhibitor of IL-4-induced proliferation. These antibodies will be useful in dissecting a wide array of activities attributed to IL-4.


This article has been cited by other articles:


Home page
J. Immunol.Home page
B. Zhou, M. B. Headley, T. Aye, J. Tocker, M. R. Comeau, and S. F. Ziegler
Reversal of Thymic Stromal Lymphopoietin-Induced Airway Inflammation through Inhibition of Th2 Responses
J. Immunol., November 1, 2008; 181(9): 6557 - 6562.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. R. Herbert, T. Orekov, C. Perkins, M. E. Rothenberg, and F. D. Finkelman
IL-4R{alpha} Expression by Bone Marrow-Derived Cells Is Necessary and Sufficient for Host Protection against Acute Schistosomiasis
J. Immunol., April 1, 2008; 180(7): 4948 - 4955.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Barnes, A. Vidrich, M.-L. Wang, G. D. Wu, F. Cominelli, J. Rivera-Nieves, G. Bamias, and S. M. Cohn
Resistin-Like Molecule beta (RELMbeta/FIZZ2) Is Highly Expressed in the Ileum of SAMP1/YitFc Mice and Is Associated with Initiation of Ileitis
J. Immunol., November 15, 2007; 179(10): 7012 - 7020.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Mora, L. M. Stephenson, B. Enerson, J. Youn, A. D. Keegan, and M. Boothby
New Programming of IL-4 Receptor Signal Transduction in Activated T Cells: Stat6 Induction and Th2 Differentiation Mediated by IL-4R{alpha} Lacking Cytoplasmic Tyrosines
J. Immunol., August 15, 2003; 171(4): 1891 - 1900.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Garhart, J. G. Nedrud, F. P. Heinzel, N. E. Sigmund, and S. J. Czinn
Vaccine-Induced Protection against Helicobacter pylori in Mice Lacking Both Antibodies and Interleukin-4
Infect. Immun., June 1, 2003; 71(6): 3628 - 3633.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Y. Karulin, M. D. Hesse, H. C. Yip, and P. V. Lehmann
Indirect IL-4 Pathway in Type 1 Immunity
J. Immunol., January 15, 2002; 168(2): 545 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Brewer, M. Conacher, C. A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander
Aluminium Hydroxide Adjuvant Initiates Strong Antigen-Specific Th2 Responses in the Absence of IL-4- or IL-13-Mediated Signaling
J. Immunol., December 15, 1999; 163(12): 6448 - 6454.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Bix, Z.-E. Wang, B. Thiel, N. J. Schork, and R. M. Locksley
Genetic Regulation of Commitment to Interleukin 4 Production by a CD4+ T Cell-intrinsic Mechanism
J. Exp. Med., December 21, 1998; 188(12): 2289 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Noben-Trauth, L. D. Shultz, F. Brombacher, J. F. Urban Jr., H. Gu, and W. E. Paul
An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice
PNAS, September 30, 1997; 94(20): 10838 - 10843.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M Kondo, T Takeshita, N Ishii, M Nakamura, S Watanabe, K Arai, and K Sugamura
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4
Science, December 17, 1993; 262(5141): 1874 - 1877.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.